Rui Han Selected Research

3',5'- ditertiary- butiary- 4'- methoxycarboxylchalcone

4/2009	Gene expression analysis of human promyelocytic leukemia HL-60 cell differentiation and cytotoxicity induced by natural and synthetic retinoids.
4/2009	Gene expression analysis of human promyelocytic leukemia HL-60 cell differentiation and cytotoxicity induced by natural and synthetic retinoids.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Rui Han Research Topics

Disease

46	Neoplasms (Cancer) 01/2022 - 03/2002
17	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 04/2022 - 05/2014
14	Breast Neoplasms (Breast Cancer) 01/2022 - 03/2002
10	Pain (Aches) 01/2022 - 09/2010
9	Inflammation (Inflammations) 07/2022 - 06/2003
9	Neoplasm Metastasis (Metastasis) 01/2022 - 10/2003
9	Lung Neoplasms (Lung Cancer) 01/2022 - 05/2014
8	Infections 02/2022 - 01/2016
6	Carcinogenesis 01/2022 - 01/2016
6	Fibrosis (Cirrhosis) 01/2021 - 03/2005
6	Adenocarcinoma of Lung 01/2021 - 01/2014
5	Liver Neoplasms (Liver Cancer) 01/2021 - 01/2018
5	Hepatocellular Carcinoma (Hepatoma) 01/2021 - 01/2018
4	Wounds and Injuries (Trauma) 07/2022 - 07/2014
4	Neuralgia (Stump Neuralgia) 08/2021 - 01/2019
4	Hypertension (High Blood Pressure) 02/2021 - 01/2015
4	COVID-19 01/2021 - 01/2020
4	Melanoma (Melanoma, Malignant) 12/2016 - 01/2003
4	Leukemia 04/2009 - 01/2004
4	Graves Disease (Basedow Disease) 09/2008 - 06/2003
3	Diabetic Foot 07/2022 - 07/2014
3	Chronic Pain 01/2022 - 09/2013
3	Peripheral Nervous System Diseases (PNS Diseases) 01/2022 - 01/2016
3	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2021 - 01/2016
3	Papillomavirus Infections 12/2019 - 12/2018
3	Osteoarthritis 05/2019 - 05/2013
3	Hemorrhagic Shock 02/2019 - 08/2011
3	Type 2 Diabetes Mellitus (MODY) 01/2019 - 12/2015
3	Laryngeal Neoplasms (Laryngeal Cancer) 01/2016 - 12/2013
3	Graves Ophthalmopathy 09/2008 - 03/2005
2	Hypertrophy 01/2022 - 04/2011
2	Malnutrition (Nutritional Deficiencies) 01/2022 - 12/2019
2	Parkinson Disease (Parkinson's Disease) 01/2022 - 01/2021
2	Low Back Pain (Lumbago) 01/2022 - 01/2022
2	Asthma (Bronchial Asthma) 08/2021 - 01/2015
2	Hypotension (Low Blood Pressure) 02/2021 - 08/2012
2	Lymphatic Metastasis 01/2021 - 01/2021
2	Chronic Obstructive Pulmonary Disease (COPD) 01/2021 - 02/2015

Drug/Important Bio-Agent (IBA)

19	Proteins (Proteins, Gene)FDA Link 01/2022 - 03/2011
9	CytokinesIBA 01/2022 - 01/2006
9	Metformin (Glucophage)FDA LinkGeneric 01/2022 - 01/2014
8	Messenger RNA (mRNA)IBA 01/2021 - 10/2003
7	Interleukin-6 (Interleukin 6)IBA 01/2022 - 01/2014
7	Biological ProductsIBA 01/2022 - 01/2017
7	Biomarkers (Surrogate Marker)IBA 01/2022 - 10/2020
7	osimertinibIBA 01/2022 - 01/2018
6	Tyrosine Kinase InhibitorsIBA 04/2022 - 12/2015
6	ErbB Receptors (EGF Receptor)IBA 01/2022 - 12/2015
6	Peptides (Polypeptides)IBA 01/2022 - 06/2017
5	Therapeutic UsesIBA 01/2021 - 01/2016
4	Pharmaceutical PreparationsIBA 01/2022 - 01/2017
4	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 01/2003
4	Caspase 3 (Caspase-3)IBA 01/2021 - 03/2005
4	Paclitaxel (Taxol)FDA LinkGeneric 07/2016 - 06/2003
3	HydrogelsIBA 04/2022 - 01/2021
3	Anaplastic Lymphoma KinaseIBA 04/2022 - 10/2020
3	Phosphotransferases (Kinase)IBA 01/2022 - 04/2020
3	Small Interfering RNA (siRNA)IBA 01/2022 - 09/2013
3	CrizotinibIBA 12/2021 - 06/2016
3	PolymersIBA 01/2021 - 06/2017
3	Phosphatidylinositols (Phosphatidylinositol)IBA 01/2021 - 04/2020
3	Oncogene Proteins (Oncogene Protein)IBA 01/2021 - 01/2016
3	Histone Deacetylase InhibitorsIBA 01/2021 - 11/2017
3	AcidsIBA 01/2021 - 01/2014
3	C-Reactive ProteinIBA 10/2020 - 01/2015
3	Formaldehyde (Formol)FDA Link 01/2020 - 09/2013
3	Gefitinib (Iressa)FDA Link 12/2019 - 05/2014
3	CholesterolIBA 01/2017 - 01/2015
3	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2016 - 09/2010
3	CollagenIBA 07/2014 - 01/2003
3	salicylhydroxamic acid (SHAM)IBA 06/2013 - 08/2011
3	Troleandomycin (TAO)FDA Link 09/2008 - 03/2005
3	ResveratrolIBA 08/2005 - 08/2004
2	LipopolysaccharidesIBA 01/2022 - 07/2013
2	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 01/2015
2	Analgesics (Analgesic Drugs)IBA 01/2022 - 01/2019
2	Amyloid (Amyloid Fibrils)IBA 01/2022 - 03/2011
2	Transcription Factors (Transcription Factor)IBA 01/2022 - 01/2020
2	Hormones (Hormone)IBA 01/2022 - 01/2018
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 08/2021 - 01/2015
2	InterleukinsIBA 03/2021 - 05/2015
2	poly(3,4-ethylene dioxythiophene)IBA 01/2021 - 06/2017
2	Coloring Agents (Dyes)IBA 01/2021 - 12/2012
2	MicroRNAs (MicroRNA)IBA 01/2021 - 04/2016
2	Valeriana extractIBA 01/2021 - 12/2020
2	Dopamine (Intropin)FDA LinkGeneric 01/2021 - 01/2019
2	Long Noncoding RNAIBA 01/2021 - 01/2020
2	RNA (Ribonucleic Acid)IBA 01/2021 - 01/2019
2	n-pentanoic acid (valeric acid)IBA 01/2021 - 12/2020
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2021 - 10/2003
2	LipidsIBA 12/2020 - 07/2016
2	Chemokine CCL3IBA 10/2020 - 04/2020
2	TOR Serine-Threonine KinasesIBA 10/2020 - 04/2020

Therapy/Procedure

24	Therapeutics 01/2022 - 05/2014
6	Drug Therapy (Chemotherapy) 01/2022 - 12/2013
4	Chinese Traditional Medicine (Traditional Chinese Medicine) 07/2022 - 05/2021
4	Transplantation 01/2019 - 10/2011
2	Aftercare (After-Treatment) 01/2022 - 12/2016
2	Pain Management 01/2022 - 01/2020
2	Chemoradiotherapy 01/2021 - 03/2014